Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: October 2024

Lebanon: Israeli attack endangers a healthcare system reliant on Hezbollah

On 1 October, Lebanon became the latest epicentre of the 2024 Middle East crisis after Israel launched a […]

October 4, 2024 Emergency medicine

The impact of increasing temperatures due to climate change on infectious diseases

AbstractGlobal temperatures will continue to rise due to climate change, with high temperature periods expected to increase in […]

October 4, 2024 State of the Art

LAMOTRIGINE tablet, orally disintegrating LAMOTRIGINE kit [Endo USA, Inc.]

Updated Date: Thu, 26 Sep 2024 00:00:00 EDT

October 4, 2024 Uncategorized

HEAD AND SHOULDERS BARE MINIMAL INGREDIENTS (pyrithione zinc) shampoo [The Procter & Gamble Manufacturing Company]

Updated Date: Thu, 26 Sep 2024 00:00:00 EDT

October 4, 2024 Uncategorized

Quantum researchers come up with a recipe that could accelerate drug development

Mathematicians have developed a recipe for upgrading quantum computers to simulate complex quantum systems, such as molecules. Their […]

October 4, 2024 Uncategorized

Study identifies potential novel drug to treat tuberculosis

A new study identified that a semi-synthetic compound can be derived from natural compounds and shows potent activity […]

October 4, 2024 Uncategorized

Lucy Letby case: what happens now?

It was the most heinous of crimes. Nurse Lucy Letby was found guilty of seven murders and seven […]

October 3, 2024 Uncategorized

Treating the symptoms of climate anxiety

When I started writing Perilous Times—a novel in which Arthurian knights return from the dead to save Britain […]

October 3, 2024 Uncategorized

IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients

IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
p p Read More

Phase 1 trial of IRL757 demonstrates good absorption and safety profile

October 3, 2024 News, Uncategorized

ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study

ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study
p p Read More

Largest real-world study demonstrates significant survival advantage

October 3, 2024 News

Posts navigation

Posts pagination

« Previous 1 … 15 16 17 18 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy